PeptiDream Inc. (TYO:4587)
Japan
· Delayed Price · Currency is JPY 2,116.00
+24.00 (1.15%)
Feb 21, 2025, 3:30 PM JST
PeptiDream Revenue
In the year 2024, PeptiDream had annual revenue of 46.68B JPY with 62.57% growth. PeptiDream had revenue of 5.07B in the quarter ending December 31, 2024, a decrease of -17.78%.
Revenue
46.68B
Revenue Growth
+62.57%
P/S Ratio
5.88
Revenue / Employee
63.77M
Employees
732
Market Cap
274.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46.68B | 17.96B | 62.57% |
| Dec 31, 2023 | 28.71B | 1.86B | 6.93% |
| Dec 31, 2022 | 26.85B | 17.49B | 186.70% |
| Dec 31, 2021 | 9.37B | -2.31B | -19.79% |
| Dec 31, 2020 | 11.68B | 9.60B | 462.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Takeda Pharmaceutical Company | 4,579.02B |
| Daiichi Sankyo Company | 1,795.99B |
| HOYA Corporation | 837.44B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,867.63B |
| Olympus | 993.33B |